Literature DB >> 34228333

Transient ischemic dilation or transient RV visualization in patients with normal SPECT stress myocardial perfusion imaging: Correlation with CT coronary artery calcium scoring and coronary angiography.

Behshad Naghshtabrizi1, Maryam Alvandi2, Zahra Shaghaghi3, Seyed Kamaledin Hadei4, Farnaz Fariba1, Mehdi Moradi1, Mohammad Ali Seif Rabie5.   

Abstract

BACKGROUND: Ancillary findings on MPI, such as transient ischemic dilation (TID) and transient right ventricular visualization (TRV), are recognized as markers of extensive CAD and predictive of adverse outcomes. They usually occur in association with stress-induced regional MPI abnormalities. However, the clinical significance of these ancillary markers in the presence of normal stress MPI is incompletely understood.
METHODS: From a cohort of 564 consecutive patients referred for clinical SPECT stress MPI, 44 patients had normal stress SPECT MPI and either TID (n = 28) or TRV (n = 16). These imaging findings were correlated with CT coronary calcium (CAC), CT coronary angiography (CTA), and invasive coronary angiography (ICA) in patients with severe CAC ≥ 1000 HU. TID and TRV were quantified as stress/rest ratios. Severe CAD was defined as > 70% luminal stenosis on CTA or ICA.
RESULTS: The median TID ratio was 1.23, with a range of 1.13-1.48; the median TRV ratio was 1.30, with a range of 1.20-1.48. Of 44 patients with TID or TRV, only 9 patients (20.5%) had severe obstructive > 70% CAD by angiography (6 of 28 patients (21.5%) with TID and 3 of 16 patients (19%) with TRV). Severe multi-vessel CAD occurred in only 2 of 44 patients (4.5%). In contrast, of 9 patients with CAC > 1000 HU, 6 (67%) had severe obstructive CAD.
CONCLUSION: In patients with normal stress SPECT MPI and TID or TRV, the incidence of severe obstructive CAD was relatively low and predominantly single-vessel CAD. These findings do not support the concept that TID or TRV with normal stress MPI is predictive of high-risk CAD.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Keywords:  Balanced ischemia; Coronary CT angiography; Myocardial perfusion imaging (MPI); Transient RV visualization; Transient ischemic dilation (TID)

Mesh:

Substances:

Year:  2021        PMID: 34228333     DOI: 10.1007/s12350-021-02704-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  4 in total

1.  Significance of increased right ventricular uptake on 99mTc-sestamibi SPECT in patients with coronary artery disease.

Authors:  F Mannting; Y V Zabrodina; C Dass
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

2.  Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD.

Authors:  Aiden Abidov; Jeroen J Bax; Sean W Hayes; Ishac Cohen; Hidetaka Nishina; Shunichi Yoda; Xingping Kang; Fatma Aboul-Enein; James Gerlach; John D Friedman; Rory Hachamovitch; Guido Germano; Daniel S Berman
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

3.  The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images.

Authors:  Louise Emmett; Michael Magee; S Ben Freedman; Hans Van der Wall; Vivienne Bush; Joseph Trieu; William Van Gaal; Kevin C Allman; Leonard Kritharides
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

Review 4.  Diagnosing CAD: additional markers from myocardial perfusion SPECT.

Authors:  Guang-Uei Hung
Journal:  J Biomed Res       Date:  2013-09-30
  4 in total
  1 in total

1.  Assessing the prevalence and predicting factors of an abnormal gated myocardial perfusion SPECT in asymptomatic patients with type 2 diabetes.

Authors:  E Hosseinzadeh; Mohammadali Ghodsirad; T Alirezaie; M Arfenia; M Amoui; E Pirayesh; G Norouzi; S Khoshbakht
Journal:  Int J Cardiovasc Imaging       Date:  2021-09-05       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.